Lack of effect in vivo of clofibrate on adrenal steroid secretion

Eur J Clin Pharmacol. 1989;36(1):87-9. doi: 10.1007/BF00561031.

Abstract

Clofibrate inhibits the synthesis of adrenal steroids when administered in vitro. In the present study the effect in vivo of clofibrate on adrenal steroid secretion has been investigated. Basal levels of plasma progesterone, corticosterone, aldosterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol, dehydroepiandrosterone sulphate and dehydroepiandrosterone, and their response to ACTH 1 mg im, were not reduced by chronic administration of clofibrate 2 g per day p.o. for 8 to 34 days to 6 hyperlipidaemic men.

MeSH terms

  • 17-alpha-Hydroxyprogesterone
  • Adrenal Cortex Hormones / metabolism*
  • Adrenal Glands / drug effects*
  • Adrenal Glands / metabolism
  • Adrenocorticotropic Hormone / pharmacology
  • Adult
  • Clofibrate / pharmacology*
  • Humans
  • Hydroxyprogesterones / metabolism
  • Hyperlipidemias / metabolism*
  • Male
  • Middle Aged
  • Progesterone / metabolism*

Substances

  • Adrenal Cortex Hormones
  • Hydroxyprogesterones
  • Progesterone
  • 17-alpha-Hydroxyprogesterone
  • Adrenocorticotropic Hormone
  • Clofibrate